John Fairbanks
Analyst · Eric Stine from Craig-Hallum. Your line is open
Good afternoon. As Don highlighted during his comments, we operated well in the third quarter and made solid progress toward our goal to expand and diversify our business. Despite a 6% decline in total revenue, we grew gross profit by 24% to $6.4 million, achieved a 22% gross margin, a full six-point improvement versus the third quarter of 2015. Our net loss of $3.1 million increased and our adjusted EBITDA of $1.5 million decreased versus last year, but reflected $1.1 million of expense associated with our patent enforcement actions. Excluding these patent enforcement costs, our net loss and adjusted EBITDA would have improved versus the third quarter last year. And importantly we completed the pilot line in our East Providence facility, initiated our joint development efforts with BASF, and prepared for the launch during the second half of 2017 of our new product optimized for the power market. I'd like to start by running through our reported financial results for the third quarter and the first nine months of 2016 at a summary level. Third quarter total revenue declined 6% year-over-year to $29.6 million. Third quarter GAAP net loss was $3.1 million or $0.13 per share versus a net loss of $2.5 million or $0.11 per share last year. Third quarter adjusted EBITDA was $1.5 million, compared to $1.7 million a year ago. Overall results in the third quarter this year reflected two notable items. First, during the quarter we incurred an expense $700,000 of financing costs as a result of our decision to temporarily delay the Plant 2 construction project and related financing. During the quarter, we had completed negotiations and documentation at all approvals in hand and we’re prepared to close the debt facility required to fund the project. However, as Don discussed, we decided to temporarily to delay both the project and the financing to better align the plan capacity expansion with our assessment of demand during the 2018 to 2020 time period. Second, during the quarter we incurred $1.1 million of patent enforcement costs versus $200,000 last year. Had we not incurred these financing in patent enforcement costs, our net loss would have improved to approximately $1.3 million in the third quarter of 2016 versus $2.3 million last year and adjusted EBITDA would have improved to approximately $2.7 million in the third quarter of 2016 versus $1.8 million last year. We define adjusted EBITDA’s net income or loss before interest, taxes, depreciation, amortization, stock-based compensation expense, and other items that we do not believe are indicative of our core operating performance. The first nine months of 2016 total revenue increased 6% to $90.1 million, driven by growth in shipments to the multi-year South Asia petrochemical project. GAAP net loss improved to $6.3 million or $0.27 per share in 2016 versus a net loss of $8.1 million or $0.35 per share last year. And adjusted EBITDA for the first nine months of 2016 was $6.1 million, up from $3.7 million a year ago. Again, net loss and adjusted EBITDA for the first nine months of 2016 improved versus last year despite the increase in patent enforcement costs and financing costs incurred this year. I’ll now provide additional detail on the components of our results. First, I’ll discuss revenue. Third quarter total revenue consists of products revenue of $28.9 million and research services revenue of approximately $700,000. For the first nine months of 2016, products revenue was $88.3 million and research services revenue was $1.8 million. During the third quarter, products revenue declined 7% versus last year. Strong revenue in the Asian market led by record quarterly shipments to the South Asia petrochemical project was offset by the decline in subsea demand and the recent weakness in the North American and European petrochemical and refinery markets. During the quarter, shipments increased 13% to 11.8 million square feet of aerogel blankets, while our average selling price decreased by 18% to $2.44 per square foot. This decrease in average selling price reflected a year-over-year decline in the mix of our high price subsea products in combination with an increase in the proportion of our total revenue derived from the South Asia petrochemical project, which is characterized by project pricing established in 2013 and a high mix of lower priced 5-millimeter products. Manufacturing productivity was strong. Total production during the quarter exceeded 12.4 million square feet of aerogel blankets, which included an increase of 600,000 square feet of finished goods inventory. The first nine months of 2016, product revenue increased 5% versus last year. This growth was due principally to record revenues in our Asian market in combination with renewed growth in the building materials market, offset in part by the decline in subsea demand and the recent weakness in the North American and European downstream markets. The first nine months of the year, shipments increased by 11% to 33.6 million square feet, while our average selling price decreased by 5% versus a year ago to $2.63 per square foot. Again, the decrease in average selling price reflected the year-over-year decline in the mix of our higher price subsea products in combination with an increase in the proportion of our total revenue derived from the lower priced South Asia petrochemical project. I’ll now turn to research services revenue. Our research services revenue is related to contract research performed principally for government agencies. Research services revenue increased to 11% during the third quarter of 2016 to approximately $700,000 and 46% during the first nine months of 2016 to $1.8 million. This growth was due to the relative value and timing of research contracts versus last year. For the full year, we expect research services revenue to be approximately $2.3 million, representing a 15% growth versus last year. This expectation is reflected in our 2016 full-year financial outlook. Next, I’ll discuss gross profit. During the third quarter, gross profit grew 24% to $6.4 million and our gross margin of 22% represented an increase of six points from the third quarter of 2015. Gross profit was $19.6 million for the first nine months of the year and our gross margin of 22% is represented the increase of five full points over last year. The significant improvement in gross margin during both the third quarter and the first nine months of 2016 was due principally to volume growth supported by the third production line, enhanced manufacturing productivity, and solid year-over-year improvement in manufacturing yields. In addition, you'll recall that we experienced the CO2 supply disruption last year that temporarily depressed our gross margin by two points during the third quarter and by one point during the first nine months of 2015. Next, I’ll discuss the operating expenses. Third quarter operating expenses grew by $1.2 million or 15% to $8.8 million. This increase in third quarter operating expense included $900,000 increase in patent enforcement costs, $300,000 for increased investment in sales personnel and marketing programs, and $200,000 for increased research and development activities, offset in part by a $200,000 a year-over-year reduction in all other operating expenses during the quarter. For the first nine months of 2016, operating expenses increased by $2.4 million or 10% to $25.1 million. This increase in year-to-date operating expenses included a $1.5 million increase in patent enforcement costs and $1.1 million for increased investment in sales personnel and marketing programs, offset again in part by a $200,000 year-over-year reduction in all other operating expenses during the period. Overall, the increase in our quarterly and year-to-date operating expenses reflects our commitment to expand, protect, and defend our technology to diversify our markets and to position ourselves to grow. Next, I'll discuss our balance sheet and cash flow. We generated $3.8 million of cash from operating activities during the third quarter, consisting of $1.5 million in adjusted EBITDA and $2.3 million in cash generated through a reduction in working capital investments. This working capital reduction was a result of a $5.1 million reduction in accounts receivable balances, offset in part by investments of $1.1 million in inventories, $1.7 million in all other working capital items. Capital expenditures during the quarter totaled $2.3 million, included expenditures related to Plant 2 engineering designs, equipment to manufacture products for the power market, destruction of our pilot line and other betterments and additions in our East Providence manufacturing facility. We ended the third quarter with $21.1 million of cash in minimal debt, net current assets of $39 million and shareholders' equity of $120.3 million. In addition, our $20 million revolving credit facility remains untapped. We are updating our full-year financial outlook for 2016. The total revenue is expected to range between $118 million and $122 million, a refinement of prior guidance of $117 million to $125 million. Net loss is expected to range between $9.4 million and $10.6 million, down from prior guidance of between $6.8 million and $8.6 million. Adjusted EBITDA is expected to range between $5.4 million and $6.4 million, down from our prior guidance of between $7 million and $8.5 million. GAAP EPS is expected to range between a loss of $0.41 and a loss of $0.45 per share, down from our prior guidance of a loss of between $0.30 and $0.37 per share. This GAAAP EPS guidance assumes weighted average shares outstanding of 23.2 million shares for the year. This 2016 outlook also assumes depreciation and amortization of between $9.7 million and $9.8 million, stock-based compensation of between $5.3 million and $5.4 million, and interest and other expenses of $800,000 to include $700,000 of financing costs associated with our decision to temporarily delay the Statesboro manufacturing expansion and its related financing In addition, this revised financial outlook includes between $3.5 million and $3.7 million of costs and expenses associated with our patent enforcement actions this year. As always, product mix and the timing of project work can create quarterly and annual variability. We may incur charges, realized gains or losses, incur additional financing and interest expense, or experience other events in 2016 that could cause our result to very materially from this outlook. I’ll now turn the call back to Blair for questions-and-answers.